MUPATIN AB (Acebrophylline (100mg) + Acetylcysteine (600mg))

Mupatin Ab Tablet is indicated for the management and prevention of asthma, along with alleviating symptoms associated with chronic obstructive pulmonary disease, bronchitis, and complications arising from pulmonary cystic fibrosis. This medication assists in relaxing the muscles within the airways, enhancing respiratory ease. It can be administered with or without food, with the dosage and duration tailored to individual patient needs as determined by a healthcare professional. The prescribed dose will depend on the specific medical condition and the individual’s response to treatment. Adherence to the prescribed regimen is crucial; discontinuing the medication prematurely may lead to a resurgence of symptoms or deterioration of the condition. It is essential to inform your healthcare provider about any concurrent medications as interactions may occur. If any concerning side effects arise, seeking medical advice promptly is advised. Alcohol consumption should be avoided during treatment, as it may intensify drowsiness. Self-medication is strongly discouraged, and sharing this medication with others is not advisable. Prior to initiating treatment, patients should disclose any history of kidney or liver disease, as well as any plans regarding pregnancy or breastfeeding, to ensure safe and effective use. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.